The National Biotechnology Development Agency (NABDA) says its researchers have identified three candidate drugs to be repurposed for the treatment of Lassa fever.
Abdullahi Mustapha, director-general of NABDA, disclosed this yesterday in an interview with NAN.
Mustapha said scientists at the genetics, genomics, and bioinformatics department of the agency, led by Oyekanmi Nash, its director, worked with other researchers on the discovery.
“This is NABDA’s contribution towards finding a lasting solution to Lassa fever disease in Nigeria,” he said.
“Diseases are increasing on a yearly basis. So, NABDA has repositioned and repurposed three candidate drugs for the treatment of Lassa fever.”